Cancer Treatment in Mumbai for Patients from Mauritius: Planning Care and Follow-Up from Home

Can patients from Mauritius access cancer treatment in Mumbai?

Yes. Patients from Mauritius can travel to Mumbai for oncology care covering chemotherapy, radiation therapy, surgical oncology, and structured follow-up planning. Lilavati International in Bandra West, Mumbai, is a JCI- and NABH-accredited quaternary-care hospital offering specialist oncology support alongside dedicated international patient-care services. No referral appointment is required for emergency presentations.

Why do international patients choose Mumbai for cancer treatment?

Mumbai is one of India's primary destinations for oncology care, offering access to multi-disciplinary cancer teams, advanced imaging, and surgical infrastructure within a single hospital campus. For patients from Mauritius, the combination of English-language care, relatively short flight times, and cost-effective treatment pathways makes Mumbai a practical choice.

Key reasons Mauritius patients travel to Mumbai for oncology care:

• Access to multi-disciplinary tumour boards covering surgical, medical, and radiation oncology
• On-site CT, MRI, ultrasound, and full diagnostic laboratory services available around the clock
• Cardiac catheterisation laboratory and multiple operation theatres for complex surgical oncology cases
• ICU, SICU, and ICCU critical-care support for post-operative and high-dependency oncology patients
• Blood bank, pathology, dialysis, and endoscopy facilities on the same campus
• JCI (8th Edition) and NABH accreditation — internationally recognised quality benchmarks
• International patient-care coordination support

What oncology treatments are available at Lilavati International in Bandra West, Mumbai?

Lilavati International in Bandra West, Mumbai, supports oncology patients across the core treatment modalities. The hospital's infrastructure — including operation theatres, critical-care units, and round-the-clock diagnostic services — underpins each pathway.

For specific consultant availability or to confirm which oncology sub-specialities are currently accepting international patients, use the booking form on this page or call 022 69318050.

How should a patient from Mauritius plan cancer treatment in Mumbai?

Structured pre-travel planning reduces delays and avoids unnecessary repeat investigations once you arrive. The steps below apply whether you are seeking a first opinion, a second opinion, or continuation of an existing treatment plan.

1. Compile your medical records — gather biopsy reports, histopathology slides, all imaging (CT, MRI, PET-CT), blood results, operative notes, and a summary of any prior treatment.
2. Request a pre-travel consultation — share scanned documents with the international patient-care team at Lilavati International before booking flights. This allows the oncology team to review your case and advise on the likely duration of your stay.
3. Arrange a medical visa — Indian medical visas (MED) are available to Mauritius nationals; your hospital can provide a treatment letter to support the application.
4. Plan your stay duration — treatment timelines vary by cancer type and stage. Surgical cases may require 2–4 weeks; chemotherapy cycles may require multiple visits or an extended stay.
5. Identify a local oncologist in Mauritius — before leaving Mumbai, ask the treating team to prepare a detailed discharge summary and follow-up protocol that your Mauritius-based doctor can implement.
6. Arrange accommodation near the hospital — Lilavati International is located at Bandra Reclamation Road, Bandra West, Mumbai – 400050, with accommodation options in the surrounding area.

Can I continue cancer follow-up care in Mauritius after treatment in Mumbai?

Yes. A structured handover between your Mumbai oncology team and a local physician in Mauritius is a standard part of discharge planning for international patients. The goal is to ensure continuity of care without requiring you to remain in Mumbai for every follow-up visit.

What a good cross-border follow-up plan typically includes:

• A detailed discharge summary specifying diagnosis, treatment received, response assessment, and any ongoing medication
• A written follow-up schedule — including which blood tests, imaging, and clinical reviews are required and at what intervals
• Guidance on warning signs that should prompt urgent review (see the section below)
• A point of contact at Lilavati International for remote queries from your Mauritius-based doctor
• Clarity on when a return visit to Mumbai is clinically necessary versus when local follow-up is sufficient

Patients who have completed surgical oncology or a defined chemotherapy course are often able to manage routine follow-up locally, with periodic return visits to Mumbai for imaging review or specialist reassessment. Confirm the specific protocol with your treating oncologist before discharge.

When should a Mauritius patient seek urgent oncology review?

Seek immediate medical attention — either locally in Mauritius or by contacting your Mumbai oncology team — if any of the following occur during or after cancer treatment:

• Fever above 38°C lasting more than 24 hours, particularly during or within four weeks of chemotherapy
• Unexplained bleeding that does not resolve within a few minutes
• Severe or worsening pain at the tumour site or surgical wound
• Difficulty breathing, chest pain, or rapid heart rate
• Sudden neurological changes — confusion, weakness, vision disturbance, or difficulty speaking
• Persistent vomiting or inability to take oral medications for more than 24 hours
• Swelling, redness, or warmth in a limb (possible deep vein thrombosis)
• Any new lump or mass that was not present before treatment

If you are in Mumbai and require emergency care, Lilavati International's emergency department is on the ground floor, open 24 hours a day including public holidays. Emergency contact: 022-69318063 / 64. Ambulance: +91 97692 50010.

How does Lilavati International support cancer patients from Mauritius?

Lilavati International in Bandra West, Mumbai, is a JCI (8th Edition)- and NABH-accredited quaternary-care hospital. Its infrastructure — multiple operation theatres, ICCU, SICU, ICU, PICU, NICU, 24/7 CT, MRI, ultrasound, full diagnostic laboratory, blood bank, pathology, dialysis, and endoscopy — supports complex oncology cases that require multi-disciplinary input and critical-care backup.

For international patients from Mauritius, the hospital provides:

• Dedicated international patient-care coordination
• Round-the-clock diagnostic services — no waiting until the next business day for urgent imaging or blood results
• A single campus covering pre-operative assessment, surgery, chemotherapy administration, critical care, and post-treatment review
• Structured discharge planning with written follow-up protocols for your local physician in Mauritius
• 24/7 emergency access with no appointment required — emergency department on the ground floor, next to MRI

To discuss your case or request a pre-travel review of your oncology records, use the booking form on this page or reach out directly.

For oncology-related queries, you may also find these pages useful: Oncology at Lilavati International | Chemotherapy | Surgical Oncology | Radiation Therapy.